YM BioSciences(加拿大)

YM BioSciences

加拿大YMBioScienceswww.ymbiosciences.com是为全球病人一家从事癌症药物及急救药品研发及商业化的公司。2012年Gilead收购YMBioSciences YMBioSciencesisalifesciencesproductdevelopmentcompanythatidentifiesandadvancesadiverseportfolioofpromising cancer-relatedproductsatvariousstagesofdevelopment.YMhasprovenregulatoryandclinicaltrialexpertiseandadiversifiedbusinessmodeldesignedtoreduceriskwhileadvancingclinicalproductstowardinternationalapproval,marketingandcommercialization.TheCompanyiscurrentlyadvancingtwolate-stageproducts:Nimotuzumab:anEGFR-targetingAffinity-OptimizedAntibody™indevelopmentworldwide,targetingmultipletumortypesprimarilyincombinationwithradiationandchemoradiation,andapprovedformarketinginover12countries.AeroLEF®:aproprietary,inhaled-deliverycompositionoffentanylindevelopmentforthetreatmentofmoderatetosevereacutepain.